Back to Search Start Over

Air Pollution Particulate Matter Amplifies White Matter Vascular Pathology and Demyelination Caused by Hypoperfusion.

Authors :
Huuskonen MT
Liu Q
Lamorie-Foote K
Shkirkova K
Connor M
Patel A
Montagne A
Baertsch H
Sioutas C
Morgan TE
Finch CE
Zlokovic BV
Mack WJ
Source :
Frontiers in immunology [Front Immunol] 2021 Nov 16; Vol. 12, pp. 785519. Date of Electronic Publication: 2021 Nov 16 (Print Publication: 2021).
Publication Year :
2021

Abstract

Cerebrovascular pathologies are commonly associated with dementia. Because air pollution increases arterial disease in humans and rodent models, we hypothesized that air pollution would also contribute to brain vascular dysfunction. We examined the effects of exposing mice to nanoparticulate matter (nPM; aerodynamic diameter ≤200 nm) from urban traffic and interactions with cerebral hypoperfusion. C57BL/6 mice were exposed to filtered air or nPM with and without bilateral carotid artery stenosis (BCAS) and analyzed by multiparametric MRI and histochemistry. Exposure to nPM alone did not alter regional cerebral blood flow (CBF) or blood brain barrier (BBB) integrity. However, nPM worsened the white matter hypoperfusion (decreased CBF on DSC-MRI) and exacerbated the BBB permeability (extravascular IgG deposits) resulting from BCAS. White matter MRI diffusion metrics were abnormal in mice subjected to cerebral hypoperfusion and worsened by combined nPM+BCAS. Axonal density was reduced equally in the BCAS cohorts regardless of nPM status, whereas nPM exposure caused demyelination in the white matter with or without cerebral hypoperfusion. In summary, air pollution nPM exacerbates cerebrovascular pathology and demyelination in the setting of cerebral hypoperfusion, suggesting that air pollution exposure can augment underlying cerebrovascular contributions to cognitive loss and dementia in susceptible elderly populations.<br />Competing Interests: WM is a consultant for Rebound Therapeutics, Viseon, Imperative Care, Integra, Q’Apel, Stryker, Stream Biomedical, Spartan Micro. WM is an investor for Cerebrotech, Endostream, Viseon, Rebound, Spartan Micro, Truvic, Imperative Care, Q’Apel. The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.<br /> (Copyright © 2021 Huuskonen, Liu, Lamorie-Foote, Shkirkova, Connor, Patel, Montagne, Baertsch, Sioutas, Morgan, Finch, Zlokovic and Mack.)

Details

Language :
English
ISSN :
1664-3224
Volume :
12
Database :
MEDLINE
Journal :
Frontiers in immunology
Publication Type :
Academic Journal
Accession number :
34868068
Full Text :
https://doi.org/10.3389/fimmu.2021.785519